1. Home
  2. ANDG vs VKTX Comparison

ANDG vs VKTX Comparison

Compare ANDG & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Andersen Group Inc. Class A Common Stock

ANDG

Andersen Group Inc. Class A Common Stock

N/A

Current Price

$42.82

Market Cap

4.1B

Sector

Real Estate

ML Signal

N/A

Logo Viking Therapeutics Inc.

VKTX

Viking Therapeutics Inc.

HOLD

Current Price

$34.79

Market Cap

4.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANDG
VKTX
Founded
2002
2012
Country
United States
United States
Employees
52300
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
4.4B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
ANDG
VKTX
Price
$42.82
$34.79
Analyst Decision
Buy
Strong Buy
Analyst Count
7
7
Target Price
$31.17
$95.86
AVG Volume (30 Days)
392.5K
2.4M
Earning Date
03-17-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$16.02
N/A
Revenue Next Year
$13.67
N/A
P/E Ratio
$44.38
N/A
Revenue Growth
N/A
N/A
52 Week Low
$18.12
$22.96
52 Week High
$45.00
$43.15

Technical Indicators

Market Signals
Indicator
ANDG
VKTX
Relative Strength Index (RSI) 59.41 44.70
Support Level $34.11 $34.03
Resistance Level $45.00 $36.77
Average True Range (ATR) 2.54 2.05
MACD 0.06 -0.66
Stochastic Oscillator 78.17 3.75

Price Performance

Historical Comparison
ANDG
VKTX

About ANDG Andersen Group Inc. Class A Common Stock

Andersen Group Inc is a provider of independent tax, valuation, and financial advisory services to individuals and family offices, businesses, and institutional clients in the United States. It has strategically expanded its business to build an integrated platform of service offerings that enables the company to solve its clients' complex tax and financial challenges. The company's end-to-end services offerings include: Private Client Services, Business Tax Services, Alternative Investment Funds, and Valuation Services. The firm generates the key revenue from Private Client Services, which provide comprehensive tax and financial services for individuals and families, addressing complex client matters involving multigenerational wealth, charitable giving, and trust and estate planning.

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

Share on Social Networks: